Diaceutics PLC (DXRX) — Capital Reinvestment Ratio
Diaceutics PLC (DXRX) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow (GBX696.00K) in capital expenditures (GBX16.00K). Check Diaceutics PLC tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Diaceutics PLC Capital Reinvestment Ratio (2016–2025)
This chart tracks Diaceutics PLC's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see how efficiently does Diaceutics PLC generate cash.
Annual Capital Reinvestment Ratio for Diaceutics PLC (2016–2025)
Year-by-year Capital Reinvestment Ratio for Diaceutics PLC from 2016 to 2025. See Diaceutics PLC (DXRX) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.05x | GBX1.50 Million | GBX71.00K | ▼ -99.3% |
| 2024 | 7.12x | GBX651.00K | GBX4.63 Million | ▲ +92.1% |
| 2023 | 3.70x | GBX1.31 Million | GBX4.86 Million | ▲ +287.5% |
| 2022 | 0.96x | GBX5.10 Million | GBX4.87 Million | ▼ -90.3% |
| 2021 | 9.83x | GBX570.00K | GBX5.60 Million | ▼ -60.5% |
| 2020 | 24.88x | GBX253.00K | GBX6.29 Million | ▲ +13390.3% |
| 2017 | 0.18x | GBX1.53 Million | GBX282.92K | ▲ +328.1% |
| 2016 | 0.04x | GBX674.01K | GBX29.03K | — |